Clinical Trial Update: Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral ixazomib as maintenance therapy after initial therapy in newly diagnosed multiple myeloma patients not treated with stem cell tran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• NINLARO (ixazomib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2025-03-21